Dr. Tulshidas S. Patil

Employment

• SVKM NMIMS Global University School of Pharmacy and Technology Management Assistant Professor
  2019 - Present

Education

• NMIMS's School of Pharmacy and Technology Management Research Scholar
  2016 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Chondroitin sulfate-functionalized ultradeformable liposomes for dual effect in rheumatoid arthritis: systematic QbD development and in vivo characterization
  International Journal of Pharmaceutics 2026 DOI: 10.1016/j.ijpharm.2026.127085
  +Save
• Chondroitin sulfate-functionalized ultradeformable liposomes for dual effect in rheumatoid arthritis: Systematic QbD development and in vivo characterization
  2026 DOI: 10.2139/ssrn.6318388
  +Save
• Development, characterization, and ex-vivo evaluation of flexible membrane vesicular gel for the topical delivery of diclofenac diethylamine
  Journal of Dispersion Science and Technology 2025 DOI: 10.1080/01932691.2025.2520868
  +Save
• QbD-Enabled Development of Quercetin Dihydrate-Loaded Nanostructured Lipid Carriers: In vitro Characterization, Safety and Efficacy Assessment in Androgenetic Alopecia Mice Model
  BioNanoScience 2025 DOI: 10.1007/s12668-025-01828-3
  +Save
• Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
  Journal of Drug Delivery Science and Technology 2024 DOI: 10.1016/j.jddst.2024.105890
  +Save
• Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms24032978
  +Save
• Design, development, and characterisation of clofazimine-loaded mannosylated nanostructured lipid carriers: 33-Box-Behnken design approach
  Materials Technology 2021 DOI: 10.1080/10667857.2020.1774227
  +Save
• Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine
  Drug Development and Industrial Pharmacy 2021 DOI: 10.1080/03639045.2021.1892743
  +Save
• Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: A state of the art review
  Journal of Controlled Release 2020 DOI: 10.1016/j.jconrel.2020.01.046
  +Save
• Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need
  Journal of Drug Targeting 2019 DOI: 10.1080/1061186X.2018.1455842
  +Save